Kymera Therapeutics, Inc. - stock earnings
KYMR Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | -0.69 / -0.73 | - | 10.3 million / 15.1 million | - |
| Aug. 1, 2024 BeforeMarket | - / - | - | - / 10.9 million | 26.9 million |
KYMR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -48.6 million USD | 10.3 million USD |
| 2023Q4 | -14.4 million USD | 47.9 million USD |
| 2023Q3 | -52.9 million USD | 4.7 million USD |
| 2023Q2 | -38.8 million USD | 16.5 million USD |
| 2023Q1 | -36.6 million USD | 9.5 million USD |
| 2022Q4 | -34.0 million USD | 16.1 million USD |
| 2022Q3 | -41.1 million USD | 9.6 million USD |
| 2022Q2 | -39.7 million USD | 11.5 million USD |
| 2022Q1 | -36.4 million USD | 9.6 million USD |
| 2021Q4 | -33.9 million USD | 15.3 million USD |
| 2021Q3 | -28.6 million USD | 20.3 million USD |
| 2021Q2 | -24.7 million USD | 18.5 million USD |
| 2021Q1 | -13.1 million USD | 18.7 million USD |
| 2020Q4 | -12.7 million USD | 12.8 million USD |
| 2020Q3 | -8.0 million USD | 14.5 million USD |
| 2020Q2 | -14.0 million USD | 3.3 million USD |
| 2020Q1 | -10.9 million USD | 3.4 million USD |
| 2019Q4 | -11.5 million USD | 1.8 million USD |
| 2019Q3 | -11.4 million USD | 950000 USD |
KYMR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -147.0 million USD | 78.6 million USD |
| 2022 | -151.8 million USD | 46.8 million USD |
| 2021 | -98.0 million USD | 72.8 million USD |
| 2020 | -43.9 million USD | 34.0 million USD |
| 2019 | -41.3 million USD | 2.9 million USD |
| 2018 | -21.5 million USD | ? USD |
KYMR
Price: $37.94
52 week price:
Earnings Per Share: -2.52 USD
P/E Ratio: -13.01
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 492600
Market Capitalization: 2.3 billion